Deriving a provisional tolerable intake for intravenous exposure to silver nanoparticles released from medical devices
Laura C. Savery(United States Food and Drug Administration), Ronald P. Brown(United States Food and Drug Administration), René Viñas(The University of Texas Medical Branch at Galveston), Amber Nagy(Texas Biomedical Research Institute), Peter L. Goering(United States Food and Drug Administration), Prachi Pradeep(Research Triangle Park Foundation), Alan M. Hood(United States Food and Drug Administration), S.G. Malghan(United States Food and Drug Administration), Stephen J. Merrill(Marquette University)
Cited by 17
Related Papers
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
|Nature Biotechnology|2010|406
Bisphenol S Disrupts Estradiol-Induced Nongenomic Signaling in a Rat Pituitary Cell Line: Effects on Cell Functions
|Environmental Health Perspectives|2013|230
Silver Nanoparticle-Induced Autophagic-Lysosomal Disruption and NLRP3-Inflammasome Activation in HepG2 Cells Is Size-Dependent
|Toxicological Sciences|2016|182
CATMoS: Collaborative Acute Toxicity Modeling Suite
|Environmental Health Perspectives|2021|145
Navigating through the minefield of read-across tools: A review of in silico tools for grouping
|Computational Toxicology|2017|113